Lodaer Img

CMS Faculty Participate in International Problem-Based Learning Program for Health Sciences in Seville

From January 12th to 16th, 2026, Universidad Loyola (Seville, Spain) hosted an international intensive program focused on the innovative teaching methodology of Problem-Based Learning (PBL) tailored to health sciences education. Supported by the Erasmus+ framework, this initiative brought together faculty from higher education institutions across Europe and beyond to explore active, student-centered pedagogies and collaborative problem-solving approaches. The week-long program offered comprehensive […]

EMBO Installation Grant awarded to CBR Researcher

Nina Schmolka, a researcher at the Católica Biomedical Research Centre (CBR), is the only scientist in Portugal to be awarded an EMBO Installation Grant 2026 by the European Molecular Biology Organization (EMBO). She is among the ten researchers selected annually for this prestigious funding programme. The grant will support the establishment of the Developmental Haematopoiesis […]

Up to €2,500 for student initiatives that contribute to inclusion and diversity, sustainability, or wellbeing

As part of the Transform4Europe (T4EU) Alliance, the third call for Student Initiatives is now open, offering student clubs or individual teams of students at Católica the opportunity to receive funding to bring their ideas to life and contribute to the improvement of their campi and the European university community. This initiative aims to encourage the creation […]

Professor Paula Ravasco participates as keynote speaker at the ISCORT 2026 Congress

Professor Paula Ravasco, from the Católica Medical School, was invited to deliver a scientific keynote lecture at the ISCORT 2026 Congress, organised by the Israeli Society of Clinical Oncology and Radiation Therapy. The lecture, entitled “Nutrition in cancer care: fundamental knowledge for oncologists”, focused on the essential role of nutrition in oncology care, highlighting the […]

Global Pharma 2026: Executive Course Brings Together Leaders of the Pharmaceutical Industry in Portugal

Between March and May 2026, the Católica Medical School and Hospital da Luz Lisboa will host the fourth edition of the Global Pharma Executive Course, a flagship training program aimed at leaders in the pharmaceutical industry. According to João Santos Pereira, Executive Director of the Católica Medical School, “For the Católica Medical School, it is […]

Duas de Prosa (Podcast) | How to get back into a sleep routine after vacation

Yesterday, January 7th, our Executive Director, Ana Rita Constante, took part in the podcast “Duas de Prosa” on Antena 1, with journalist Filomena Crespo, to talk about the role of sleep in child development, as well as the importance of routines after the recent festive period. 👉 Listen to the Podcast at: https://www.rtp.pt/play/p15730/e900743/duas-de-prosa-podcast

Public Habilitation Exams in Vascular Biology: Congratulations, Professor Cláudio Franco!

Professor Cláudio Areias Franco, Católica Biomedical Research Centre researcher and faculty member at the Católica Medical School, successfully completed the Public Habilitation Exams in the field of Vascular Biology. He was approved unanimously by all members of the examination committee. Cláudio Franco graduated in Biochemistry from the University of Porto and holds a PhD in Protein […]

Forward!25 Fall Edition Demo Day

Last Saturday, the Forward! teams took the stage at Católica Lisbon School of Business and Economics to pitch the result of weeks of hard work, customer discovery, prototyping, and interation. The quality of the pitches, the progress made, and the maturity of the thinking showed exactly why programs like Forward! matter: execution beats ideas, every single time. […]

Photographing a mole and detecting skin cancer? Platform “made in Portugal” speeds up diagnosis

With a 90% confidence rate, reducing doubts among family doctors and delays in diagnosis are the main objectives of the “Dermamatica” technology, which may be implemented in Portugal. When a patient suspects that a skin lesion may be skin cancer , they are usually evaluated by a family doctor, who can rule out a high-risk case. To reduce […]